Order results by:
| Issue | Title | |
| Vol 7, No 2 (2011) | LIPRIMAR®. FIFTEEN YEARS OF EVIDENCE | Abstract similar documents |
| A. V. Susekov, N. V. Khokhlova | ||
| "... The evidences for statin use in cardiology are presented. Especially hypolipidemic efficacy ..." | ||
| Vol 9, No 4 (2013) | STATINS IN PREVENTION OF ISCHEMIC STROKE | Abstract similar documents |
| A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk | ||
| "... The evidence base of statin therapy in primary and secondary prevention of ischemic stroke ..." | ||
| Vol 15, No 4 (2019) | Evidence, Guidelines and Treatment Algorithms for Patients with Arterial Hypertension and Dyslipidemia: the Need for Compromise and Optimization of Tactics in Practical Healthcare | Abstract similar documents |
| O. M. Drapkina, M. V. Ezhov, S. R. Gilyarevsky, R. N Shepel | ||
| "... . The evidence base of modern drugs for preventing the development of cardiovascular complications ..." | ||
| Vol 6, No 2 (2010) | EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES | Abstract similar documents |
| A. N. Meshkov | ||
| "... is - the lower risk of cardiovascular diseases and their complications are. Efficacy and safety of atorvastatin ..." | ||
| Vol 6, No 5 (2010) | THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| S. N. Tereshchenko, N. G. Chuich, A. L. Syrkin, D. A. Andreev, A. V. Kolchurina, V. P. Terentev, A. Yu. Borozinets | ||
| "... Aim. To study the effect of atorvastatin on the rate of atrial fibrillation (AF) recurrence after ..." | ||
| Vol 14, No 5 (2018) | Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome | Abstract PDF (Eng) similar documents |
| Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal | ||
| "... -term safety and efficacy of full dose rosuvastatin and atorvastatin in patients with acute coronary ..." | ||
| Vol 4, No 2 (2008) | EFFECT OF GENES SLCO1B1 AND MDR1 POLYMORPHISM ON ATORVASTATIN PHARMACOKINETICS AND PHARMACODYNAMICS IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: RESULTS OF PILOT PHARMACOGENETICS STUDY | Abstract similar documents |
| A. V. Semenov, D. A. Sichev, V. G. Kukes | ||
| "... Aim. To study effects of genes SLCO1B1 and MDR1 polymorphism on atorvastatin pharmacokinetics ..." | ||
| Vol 10, No 4 (2014) | STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN | Abstract similar documents |
| N. G. Gogolashvili | ||
| "... The possibility of atorvastatin in reducing the risk of periprocedural myocardial infarction ..." | ||
| Vol 13, No 3 (2017) | ACUTE ATORVASTATIN RECAPTURE THERAPY IN CORONARY ARTERY BYPASS GRAFTING | Abstract similar documents |
| A. V. Panov, M. L. Gordeev, A. A. Zhloba, T. F. Subbotina, I. V. Suhova, M. I. Buthashvili, I. T. Abesadze, M. Z. Alugishvili, N. L. Lohovinina, K. V. Korzhenevskaya, M. V. Solovyova, L. V. Mihaylova, E. S. Alekseevskaya | ||
| "... Aim. To assess the safety of the application of high-dose atorvastatin and its effect on metabolic ..." | ||
| Vol 9, No 5 (2013) | THE ROLE OF LIPOTROPIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE BEFORE AND AFTER CORONARY REVASCULARIZATION | Abstract similar documents |
| R. N. Adzhiev, M. S. Safarova, M. V. Ezhov | ||
| Vol 4, No 3 (2008) | DYNAMICS OF THE HEART RATE VARIABILITY IN PATIENTS WITH ATRIAL FIBRILLATION DURING ATORVASTATIN THERAPY | Abstract similar documents |
| E. S. Kozlova, E. E. Galaktionova, F. A. Nemchuk, Yu. M. Lopatin | ||
| "... ) and paroxysmal atrial fibrillation (AF) during atorvastatin therapy. Material and methods. 60 patients with IHD ..." | ||
| Vol 6, No 6 (2010) | COMPARATIVE EFFICACY OF THE STATINS IN PREVENTING AND TREATING OF THE CORONARY HEART DISEASE | Abstract similar documents |
| S. V. Shalaev, Z. M. Safiullina, L. V. Kremneva, O. V. Abaturova | ||
| "... to therapy with atorvastatin and rosuvastatin was demonstrated in recent studies. The advantage of aggressive ..." | ||
| Vol 11, No 1 (2015) | ASPECTS OF LIPID-LOWERING THERAPY WITH ATORVASTATIN IN PATIENTS WITH MYOCARDIAL INFARCTION FROM THE PERSPECTIVE OF PERSONALIZED MEDICINE | Abstract similar documents |
| M. V. Solodun, S. S. Yakushin | ||
| "... on the efficacy of atorvastatin therapy and the incidence of the combined endpoint in patients after myocardial ..." | ||
| Vol 9, No 4 (2013) | EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE | Abstract PDF (Eng) similar documents |
| G. A. Batrak, S. E. Miasoedova, O. I. Kelesh | ||
| "... antihypertensive and glucose-lowering therapy. Patients of group 1 were additionally receiving atorvastatin 20 mg ..." | ||
| Vol 11, No 5 (2015) | Efficacy of atorvastatin therapy in prevention of postoperative atrial fibrillation in patients with ischemic heart disease | Abstract similar documents |
| O. A. Rubanenko | ||
| "... Aim. To evaluate the efficacy of atorvastatin therapy in prevention of atrial fibrillation (AF ..." | ||
| Vol 1, No 3 (2005) | PHARMACOLOGICAL CORRECTION OF CEREBRAL BLOOD FLOW DISTURBANCES IN WOMEN WITH ARTERIAL HYPERTENSION IN POSTMENOPAUSE | Abstract similar documents |
| V. V. Yakusevich, M. E. Mozheiko, N. V. Sudareva, N. E. Semyonova | ||
| "... with initial dislipidemia were prescribed lipid reducing drug atorvastatin in 10mg daily dose additionally ..." | ||
| Vol 19, No 5 (2023) | Nephroprotective effect of atorvastatin at a dose of 80 mg in patients with ST-segment elevation myocardial infarction with an invasive treatment strategy | Abstract similar documents |
| A. D. Gavrilko, E. M. Mezhonov, S. V. Shalaev, D. V. Krasheninin | ||
| "... Aim. To study the effectiveness of atorvastatin 80 mg, prescribed immediately prior emergency ..." | ||
| Vol 6, No 3 (2010) | HOMOEOPATHY IN THE ERA OF EVIDENCE BASED MEDICINE | Abstract similar documents |
| N. P. Kutishenko | ||
| "... Homoeopathy in the era of evidence based medicine. ..." | ||
| Vol 6, No 4 (2010) | RECENT ADVANCES IN THE APPLICATION OF HIGH DOSES OF ATORVASTATIN IN PATIENTS WITH CORONARY HEART DISEASE | Abstract similar documents |
| M. V. Ezhov | ||
| "... The results of the recently completed clinical studies on the efficacy of atorvastatin in high ..." | ||
| Vol 14, No 2 (2018) | MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | Abstract similar documents |
| L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov | ||
| "... of therapy with atorvastatin in different doses in patients with acute ST-segment elevation myocardial ..." | ||
| Vol 12, No 6 (2016) | THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 | Abstract PDF (Eng) PDF (Eng) similar documents |
| S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov | ||
| "... .5%, whereas prescription of atorvastatin and rosuvastatin increased from 31.4% to 64.5% and from 3.6% to 9 ..." | ||
| Vol 14, No 6 (2018) | Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study) | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, N. A. Dmitrieva, S. V. Blagodatskikh, O. V. Lerman, T. A. Gomova, S. I. Drozdetsky, V. V. Skibitskiy, E. A. Kudryashov, N. F. Puchinyan | ||
| "... visit (V0), and visits after 1 and 3 months of follow-up (V1 and V3). The use of generic atorvastatin ..." | ||
| Vol 16, No 5 (2020) | Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) | Abstract similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko | ||
| "... high (269, 90.3%) CVR. All patients were recommended to take the reproduced drugs of atorvastatin ..." | ||
| Vol 2, No 2 (2006) | METABOLIC SYSTEM OF CHOLESTEROL ELIMINATION FROM TISSUES. POSSIBILITY OF ACTIVATION ITS KEY PARTS | Abstract similar documents |
| N. V. Perova, I. N. Ozerova, V. A. Metelskaya | ||
| Vol 9, No 4 (2013) | USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES? | Abstract similar documents |
| V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev | ||
| "... convincing evidence base for the use of this class of drugs in the perioperative period that was the basis ..." | ||
| Vol 19, No 4 (2023) | Systematic review and meta-analysis: a critical examination of the methodology | Abstract similar documents |
| S. Yu. Martsevich S.Yu., A. R. Navasardyan, K. V. Lobastov, M. V. Mikaelyan, E. V. Mikhaylenko, A. Yu. Suvorov, I. V. Schastlivtsev, O. N. Dzhioeva, V. V. Matveev, E. S. Akimova, V. V. Sytkov, E. Dubar, O. M. Drapkina | ||
| "... Nowadays, the pyramid of evidence is the main model of decision-making for healthcare ..." | ||
| Vol 12, No 5 (2016) | Randomised Clinical Trials and Observational Studies: the Ratio in the Hierarchy of Evidence of the Efficacy of Drugs | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko | ||
| "... are the basis of modern evidence-based medicine, and that they have no alternative. Observational studies ..." | ||
| Vol 16, No 2 (2020) | Mediterranean Diet: Origin History, Main Components, Evidence of Benefits and Feasibility to Adapt to the Russian Reality | Abstract similar documents |
| D. U. Akasheva, O. M. Drapkina | ||
| Vol 2, No 3 (2006) | NEW EVIDENCES OF POSSIBILITY OF OMEGA-3 ACIDS USE FOR MYOCARDIAL INFARCTION SECONDARY PREVENTION | Abstract similar documents |
| A. I. Martinov, V. L. Chomenko | ||
| Vol 8, No 4 (2012) | ALTERNATIVE APPROACHES TO THE USE OF TWO COMPONENT ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: EVIDENCES, RECOMMENDATIONS AND REAL PRACTICE | Abstract similar documents |
| S. R. Gilyarevskiy, V. A. Orlov, I. M. Kuz'mina, A. G. Larin | ||
| "... antiplatelet agents are considered. Besides the evidence base for the practical application of new antiplatelet ..." | ||
| Vol 13, No 2 (2017) | ONCE AGAIN ABOUT THE HIERARCHY OF EVIDENCES IN MEDICINE OR WHETHER IT IS POSSIBLE TO CHOOSE THE MOST EFFECTIVE AND SAFE DRUG WITH THE HELP OF OBSERVATIONAL STUDIES | Abstract similar documents |
| S. Y. Martsevich, Yu. V. Lukina, N. P. Kutishenko | ||
| Vol 12, No 5 (2016) | Statins in Secondary Prevention of Atrial Fibrillation | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin | ||
| "... Aim. To study the effect of atorvastatin on the progression of the arrhythmia in hypertensive ..." | ||
| Vol 10, No 4 (2014) | EVIDENCE BASE OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE USE IN PATIENTS WITH STROKE AND ITS CONSEQUENCES | Abstract similar documents |
| A. D. Ehrlikh, N. A. Gratsianskii | ||
| "... practice in Russia, despite the absence of clear evidence of neuroprotection in stroke. Most clinical ..." | ||
| Vol 1, No 3 (2005) | EFFICIENCY AND SAFETY ASSESSMENT OF GENERIC ATORVASTATINE IN PATIENTS WITH HYPERLIPIDEMIA | Abstract similar documents |
| J. E. Semyonova, S. Y. Martsevich, N. V. Perova, A. M. Olferiev, N. P. Kutishenko, N. Y. Ivanenkova, N. A. Dmitrieva, A. A. Serazhim | ||
| "... дженериков аторвастатина - препарата Тулип в сравнении с дженериком симвастатина Вазилипом у пациентов с ..." | ||
| Vol 16, No 2 (2020) | Treatment of Patients with COVID-19 and Concomitant Cardiovascular Diseases: Do not Forget About the Principles of Evidence-based Medicine | Abstract similar documents |
| S. Yu. Martsevich | ||
| "... of a viral disease, as well as the absence of any clinical evidence for this hypothesis. The opinion ..." | ||
| Vol 17, No 2 (2021) | Clinical Trials Evaluating Drug Therapy: Types, Reliability of Results, Place in Modern Evidence-Based Medicine | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina, M. M. Lukyanov, O. M. Drapkina | ||
| "... The article discusses the main methods of evidence in modern medicine. Special attention is paid ..." | ||
| Vol 15, No 1 (2019) | Pharmacological Basis of the Clinical Efficacy of Varenicline Used to Facilitate Smoking Cessation | Abstract similar documents |
| S. R. Gilyarevskiy | ||
| "... of varenicline and evidence of its clinical efficacy and safety, including in patients with concomitant ..." | ||
| Vol 13, No 4 (2017) | USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA | Abstract similar documents |
| O. M. Drapkina, A. S. Lishuta | ||
| Vol 6, No 6 (2010) | THE CHOICE OF DRUG FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE: CASE STUDY OF BETA-BLOCKERS | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina | ||
| "... concerning the evidence base for effects of various beta-blockers on the outcomes of cardiovascular diseases ..." | ||
| Vol 2, No 4 (2006) | QUALITATIVE DRUG: WHAT SHOULD IT LOOK LIKE? | Abstract similar documents |
| V. V. Iakusevich | ||
| "... equivalence -25%. Evidences of pharmacodynamic (therapeutic) equivalence are not required at all. At the same ..." | ||
| Vol 5, No 1 (2009) | ONCE AGAIN ABOUT BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION. WHAT SHOULD DOCTOR RECOMMEND TO THE PATIENT? | Abstract similar documents |
| S. Y. Martsevich | ||
| "... The role of beta-blockers (BB) in arterial hypertension therapy is discussed from the evidence ..." | ||
| Vol 20, No 1 (2024) | Evidence-based pharmacotherapy in cardiology. National guideline | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina, V. V. Yakusevich, S. N. Tolpygina, I. V. Samorodskaya, M. M. Lukyanov, A. V. Zagrebelny, V. A. Metelskaya, E. A. Poddubskaya, O. M. Drapkina | ||
| Vol 14, No 2 (2018) | FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova | ||
| "... up to 8.3%. When choosing among statins specialists recommended significantly more often atorvastatin ..." | ||
| Vol 13, No 2 (2017) | SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova | ||
| "... .32% of patients, enalapril 20 mg/day – 30.45%, simvastatin and atorvastatin 20 mg/day – 64.52% and 47 ..." | ||
| Vol 14, No 4 (2018) | New Clinical Aspects of Eplerenone Use in Clinical Practice | Abstract similar documents |
| S. R. Gilyarevskiy, N. G. Bendeliani, M. V. Golshmid, I. M. Kuzmina | ||
| "... The problem of the discrepancy between convincing evidences of the effectiveness of the use ..." | ||
| Vol 5, No 1 (2009) | CURRENT PRINCIPLES AND TRENDS OF ATRIAL FIBRILLATION PHARMACOTHERAPY | Abstract similar documents |
| Yu. A. Bunin | ||
| "... complications are presented. Principles and tactics of AF therapy are discussed in accordance to evidence based ..." | ||
| Vol 9, No 1 (2013) | THE EFFICACY AND SAFETY OF DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS: AMLODIPINE PLACE | Abstract similar documents |
| M. V. Lebedeva, V. D. Beketov, N. V. Maltsev, M. E. Safarova | ||
| Vol 14, No 3 (2018) | HYPOLIPIDEMIC THERAPY IN STROKE PREVENTION: EXISTING STANDARDS, EVIDENCE-BASED MEDICINE DATA AND REAL PRACTICE | Abstract similar documents |
| O. V. Gaisenok, A. N. Rozhkov, A. S. Lishuta | ||
| "... for statin use, evidence-based medicine data obtained in randomized clinical trials, and evidence from actual ..." | ||
| Vol 14, No 6 (2018) | Angiotensin Converting Enzyme Inhibitors and the Risk of Lung Cancer – New Scientific Evidences or Another Example of “Pseudo-Evidence” Medicine? | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich | ||
| Vol 1, No 1 (2005) | ARTERIAL HYPERTENSION IN RUSSIA: PROLOG STUDY AS A PROOF METHOD OF CONTEMPORARY THERAPY OPPORTUNITIES | Abstract similar documents |
| S. A. Shalnova, S. Y. Martsevich, A. D. Deev, N. P. Kutishenko, P. G. Oganov, A. N. Britov, E. G. Volkova, K. I. Ivanov, A. M. Kalinina, L. I. Katelnitskaya, G. D. Kobalava, E. V. Kokurina, A. O. Conradi, S. K. Kukushkin, Yu. M. Lopatin, N. I. Maksimov, V. Y. Mareev, I. S. Petelin, D. V. Nebieridze, G. I. Nechayev, L. A. Sokolova, A. V. Suslikov, I. G. Fomina, A. V. Shabalin, V. A. Shulman, V. V. Yakusevich, S. S. Jakushin | ||
| Vol 11, No 3 (2015) | ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I | Abstract similar documents |
| N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, O. N. Tkacheva, A. S. Lishuta | ||
| "... with simvastatin, in 75.2% of the patients treated with atorvastatin, in 59% of the patients treated ..." | ||
| Vol 10, No 6 (2014) | DIAGNOSIS AND TREATMENT OF PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA IN REAL OUTPATIENT PRACTICE (ACCORDING TO THE RECVASA REGISTRY) | Abstract similar documents |
| A. I. Ershova, A. N. Meshkov, S. S. Yakushin, M. M. Loukianov, K. A. Moseychuk, S. Yu. Martsevich, A. V. Zagrebelnyy, A. N. Vorobyev, K. G. Pereverzeva, E. A. Pravkina, A. N. Kozminskiy, S. A. Boytsov | ||
| "... atorvastatin 40 mg per day. Blood LDC levels were examined only in 5% of patients during statins therapy ..." | ||
| Vol 11, No 4 (2015) | INNOVATIVE TECHNOLOGIES IN CARDIOLOGY: FROM SURPRISE TO HABIT OR FORGETFULNESS | Abstract similar documents |
| S. R. Gilyarevskiy, M. V. Golshmid, I. M. Kuz'mina | ||
| "... Change of the status of innovative technologies depending on the received evidences is considered ..." | ||
| Vol 6, No 2 (2010) | THE MODERN ASPECTS OF CLOPIDOGREL USE | Abstract similar documents |
| E. N. Dankovtseva, D. A. Zateyshchikov | ||
| "... The possibilities and evidence base of clopidogrel use in clinical practice are discussed. Data ..." | ||
| Vol 13, No 6 (2017) | SUBFRACTION DISTRIBUTION OF APO B-CONTAINING LIPOPROTEINS DEPENDING ON THE ACHIEVEMENT OF THE TARGET LEVEL OF LOW DENSITY LIPOPROTEINS UNDER STATINS THERAPY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS | Abstract similar documents |
| I. N. Ozerova, V. A. Metelskaya, N. E. Gavrilova | ||
| "... before admission: atorvastatin (10-40 mg/day), simvastatin (20-40 mg/day), rosuvastatin (10-40 mg/day ..." | ||
| Vol 5, No 1 (2009) | SAFARI - RANDOMISED TRIAL ON COMPLEX THERAPY OF ARTERIAL HYPERTENSION AND DISLIPIDEMY. THE MAIN RESULTS | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, V. V. Yakusevich, A. D. Deev, A. A. Serazhim, T. V. Bobkova, L. P. Volkonskaya, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, J. V. Lukina, M. A. Maksimova, A. A. Serazhim, S. N. Tolpygina, E. V. Shilova | ||
| "... . Atorvastatin (Tulip, LEK) 20-40 mg OD was prescribed for HH control. Management of CG patients was performed ..." | ||
| Vol 6, No 1 (2010) | THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE | Abstract similar documents |
| Yu. V. Lukina, S. Yu. Martsevich | ||
| "... Data of the evidence based medicine about bisoprolol treatment of patients with cardiovascular ..." | ||
| Vol 6, No 4 (2010) | POSITIONS OF CALCIUM CHANNEL BLOCKER LERCANIDIPINE ACCORDING TO EVIDENCE BASED CARDIOLOGY | Abstract similar documents |
| Yu. V. Lukina, S. Yu. Martsevich | ||
| "... Data of evidence based cardiology including results of international clinical trials on efficacy ..." | ||
| Vol 11, No 2 (2015) | NEWS OF EVIDENCE-BASED MEDICINE: RESULTS OF THE IMPROVE-IT TRIAL AND THEIR IMPLICATIONS FOR CLINICAL PRACTICE | Abstract similar documents |
| S. Yu. Martsevich | ||
| Vol 10, No 5 (2014) | STATINS USE IN THE PERIOPERATIVE PERIOD ACCORDING TO THE EVIDENCE-BASED MEDICINE | Abstract similar documents |
| V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev | ||
| "... been focused on statins use. Evidence base of this drugs class use in the perioperative period serves ..." | ||
| Vol 8, No 1 (2012) | BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE | Abstract similar documents |
| M. V. Leonova | ||
| Vol 3, No 5 (2007) | LISINOPRIL USAGE IN CARDIOLOGIC PRACTICE: DATA OF EVIDENCE BASED MEDICINE | Abstract similar documents |
| N. P. Kutishenko, S. J. Martsevich | ||
| Vol 8, No 2 (2012) | THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE | Abstract similar documents |
| S. N. Tereshchenko, I. V. Zhirov, A. G. Kochetov, O. V. Uspenskaya | ||
| Vol 3, No 1 (2007) | THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION | Abstract similar documents |
| D. B. Nebieridze, A. S. Safaryan | ||
| "... and prove the possibility of a new clinical approach. Evidences support new strategic abilities of a number ..." | ||
| Vol 13, No 4 (2017) | GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS | Abstract similar documents |
| M. A. Vorobyeva, M. M. Azova, O. O. Gigani, I. V. Garmash, S. V. Villevalde, Zh. D. Kobalava | ||
| "... with atorvastatin 80 mg/day. The results were considered statistically significant at p<0.05. Results. 16 (27 ..." | ||
| Vol 14, No 2 (2018) | HYPERTENSION AND DIABETES MELLITUS TYPE 2 | Abstract similar documents |
| M. E. Statsenko, M. V. Derevyanchenko | ||
| "... , hypolipidemic therapy with atorvastatin 17.0Ѓ}4.7 mg/day and combined hypoglycemic therapy with metformin 1093 ..." | ||
| Vol 16, No 4 (2020) | Epicardial Adipose Tissue as a New Target of Therapeutic Interventions | Abstract similar documents |
| M. A. Druzhilov, T. Y. Kuznetsova | ||
| "... There is evidence of a correlation between epicardial adipose tissue and the presence and severity ..." | ||
| Vol 7, No 4 (2011) | CLINICAL IMPORTANCE OF IDIOPATHIC MITRAL ANNULAR CALCIFICATION | Abstract similar documents |
| N. S. Chipigina, G. M. Urvacheva, N. A. Shostak | ||
| "... evidences of increased risk of unfavorable cardiovascular events in patients with MAC. The current ..." | ||
| Vol 16, No 4 (2020) | Studying the Possibility of Optimizing the Statin Therapy Algorithm in Outpatient Practice | Abstract similar documents |
| D. V. Nebieridze, N. M. Akhmedzhanov, S. A. Davitashvili, A. S. Lishuta, A. S. Safaryan | ||
| "... atorvastatin (10-80 mg/day) or rosuvastatin (10-40 mg/day). Group 1 patients had visits to the doctor after 1 ..." | ||
| Vol 17, No 1 (2021) | Optimization of the Statin Therapy Algorithm in Outpatient Practice: Adherence and Economic Benefits | Abstract similar documents |
| S. A. Davitashvili, D. V. Nebieridze, N. M. Akhmedzhanov, A. S. Lishuta, A. S. Safaryan | ||
| "... atorvastatin (10-80 mg/day) or rosuvastatin (10- 40 mg/day). Group 1 patients had visits to the doctor after 1 ..." | ||
| Vol 18, No 1 (2022) | Challenges of Statin Therapy in Clinical Practice (According to Outpatient Register «PROFILE» Data) | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, A. V. Zagrebelnyy, S. N. Tolpygina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. S. Nekoshnova, I. V. Budaeva, S. V. Blagodatskikh, B. B. Aslanova | ||
| "... .2-5.3 (p<0.001). Doctors preferred atorvastatin in prescriptions (n=456, 55.4%), rosuvastatin (n=244 ..." | ||
| Vol 5, No 6 (2009) | ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS | Abstract similar documents |
| N. A. Dmitrieva, S. N. Tolpygina | ||
| "... Data of evidence based medicine which confirm efficacy of acetylsalicylic acid (ACA ..." | ||
| Vol 14, No 1 (2018) | IDENTIFICATION OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE RUSSIAN POPULATION USING THE EXAMPLE OF MOSCOW CITY AND MOSCOW REGION | Abstract similar documents |
| I. V. Sergienko, A. A. Ansheles | ||
| "... with severe HCh was 18.3%. Monotherapy with atorvastatin (34.2%) or rosuvastatin (31.8%), combined therapy ..." | ||
| Vol 13, No 4 (2017) | PREVENTION AND EVIDENCE-BASED MEDICINE ARE THE MAIN ASSISTANTS OF THE PHYSICIAN. INTERVIEW WITH PROFESSOR S.YU. MARTSEVICH | Abstract similar documents |
| N. V. Dolgushina | ||
| Vol 6, No 5 (2010) | THE USE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AFTER MYOCARDIAL INFARCTION. WHAT DO EVIDENCE-BASED MEDICINE DATA SPEAK FOR? | Abstract similar documents |
| S. Yu. Martsevich | ||
| Vol 10, No 2 (2014) | PREVALENCE RATE OF PSYCHOGENIC RISK FACTORS AMONG PATIENTS WITH ARTERIAL HYPERTENSION OF VARIOUS DEGREES ACCORDING TO CRITERIA OF EVIDENCE-BASED MEDICINE | Abstract similar documents |
| B. B. Fishman, I. N. Kochanov, A. I. Horoshevskaja, M. A. Bobyr, D. A. Shamiladze, L. A. Fomenko, V. V. Kostirkina, Yu. O. Yevstyukhina | ||
| Vol 3, No 1 (2007) | DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE | Abstract similar documents |
| S. Y. Martsevich | ||
| Vol 4, No 3 (2008) | ROLE OF BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION TREATMENT. WHAT DO EVIDENCE BASED MEDICINE DATA SHOW? | Abstract similar documents |
| S. Y. Martsevich | ||
| "... The beta-blocker role in arterial hypertension treatment is surveyed from the positions of evidence ..." | ||
| Vol 4, No 4 (2008) | CARDIOVASCULAR EVENT RISK REDUCTION WITH MEDICINES: DATA OF EVIDENCE BASED MEDICINE AND RECOMMENDATIONS TO PRACTITIONERS | Abstract similar documents |
| S. Y. Martsevich | ||
| Vol 15, No 2 (2019) | How to solve the problem of drug choice within the same class from the standpoint of evidence-based medicine? | Abstract similar documents |
| S. Yu. Martsevich | ||
| "... the standpoint of evidence-based medicine is considered in the article. Drugs belonging to the same class may ..." | ||
| Vol 20, No 4 (2024) | The evolution of evidence-based methods of acute myocardial infarction treatment: is there any reason for optimism in recent years? | Abstract similar documents |
| S. Yu. Martsevich | ||
| Vol 8, No 4 (2012) | UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION | Abstract similar documents |
| E. A. Protasova, N. V. Furman, O. V. Reshet'ko | ||
| "... categories of patients. Nevertheless, there are currently no sufficient evidences to justify ..." | ||
| Vol 20, No 4 (2024) | Should a physician use the Beers criteria when prescribing direct oral anticoagulants to elderly patients? | Abstract similar documents |
| N. M. Vorobyeva, I. P. Malaya, V. D. Zakiev, O. N. Tkacheva | ||
| "... ". This statement is based on moderate-quality evidence obtained from observational studies and network meta ..." | ||
| Vol 8, No 1 (2012) | OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES | Abstract similar documents |
| A. V. Govorin, A. P. Filev | ||
| "... For today there are convincing evidences of beneficial effect of ω-3 polyunsaturated fatty acids ..." | ||
| Vol 13, No 6 (2017) | INTEGRATION OF BIOMARKERS INTO THE PRACTICE OF TREATING PATIENTS WITH HEART FAILURE: THE ROLE OF DETERMINING THE BLOOD LEVEL OF NATRIURETIC PEPTIDES | Abstract similar documents |
| S. R. Gilyarevskiy, M. V. Golshmid, I. M. Kuzmina | ||
| "... . The most important evidences of clinical effectiveness of using biomarkers in patients with suspected heart ..." | ||
| Vol 7, No 3 (2011) | MODERN ANTIPLATELET THERAPY OF ISCHEMIC HEART DISEASE PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: DATA FROM EVIDENCE-BASED MEDICINE AND REAL PRACTICE | Abstract similar documents |
| S. Yu. Martsevich, M. L. Ginzburg, A. M. Malysheva, Yu. N. Polyanskaya, T. G. Kheliya, N. P. Kutishenko | ||
| Vol 9, No 4 (2013) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT | Abstract similar documents |
| S. Yu. Martsevich | ||
| Vol 2, No 1 (2006) | SUPRAVENTRICULAR RHYTHM DISTURBANCES TREATMENT WITH ANTIARHYTHMIC DRUG III CLASS NIBENTAN IN PATIENTS WITH ISCHEMIC HEART DISEASE (EXPERIMENTAL, CLINICAL AND MORPHOLOGICAL EVIDENCES) | Abstract similar documents |
| I. A. Latfullin, R. F. Gaifullina | ||
| Vol 17, No 4 (2021) | Approaches to Assessing the Quality of Observational Studies of Clinical Practice Based on the Big Data Analysis | Abstract similar documents |
| S. R. Gilyarevsky | ||
| "... studies in real clinical practice and determining their place in the hierarchy of evidence-based ..." | ||
| Vol 11, No 1 (2015) | MYOPATHY AS A SIDE EFFECT OF STATIN THERAPY: MECHANISMS OF DEVELOPMENT AND PROSPECTS FOR TREATMENT | Abstract similar documents |
| O. M. Drapkina, E. M. Chernova | ||
| "... prevails. Additional intake of CoQ10 seems promising, but is not evidence-based. ..." | ||
| Vol 11, No 6 (2015) | Neoatherosclerosis in the stent | Abstract similar documents |
| A. A. Komkov, V. P. Mazaev, S. V. Ryazanova | ||
| "... with restenosis, its regression, and neoatherosclerosis development. Evidences of neoatherosclerosis formation ..." | ||
| Vol 8, No 4 (2012) | EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS | Abstract similar documents |
| I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze | ||
| "... associated with osteoporosis are discussed. At the present time there are no sufficient evidences of positive ..." | ||
| Vol 16, No 5 (2020) | Clinical and Pharmacological Approaches to the Prescription of Centrally Acting Antihypertensive Drugs for Uncontrolled Arterial Hypertension | Abstract similar documents |
| A. V. Strygin, B. E. Tolkachev, A. O. Strygina, A. M. Dotsenko | ||
| "... -organs damage if not promptly relieved. Therefore, clear evidence-based recommendations of optimal ..." | ||
| Vol 6, No 3 (2010) | WHAT DOES PROVIDE A CLINICAL EFFICACY OF METOPROLOL? | Abstract similar documents |
| E. V. Kuleshova | ||
| "... in regard to development of evidence base for use of different metoprolol presentations in treatment ..." | ||
| Vol 20, No 4 (2024) | Original drugs and generics: are there any differences from the clinician’s point of view? | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, O. M. Drapkina | ||
| "... воспроизведенных лекарственных препаратов (ВЛП), а также эволюция взглядов на доказательства их биоэквивалентности ..." | ||
| Vol 17, No 4 (2021) | Obstructive sleep apnea and cardiovascular comorbidity: common pathophysiological mechanisms to cardiovascular disease | Abstract similar documents |
| M. V. Agaltsov, O. M. Drapkina | ||
| "... , direct damaging effect on the myocardium) has a great evidence base. Two other pathological components ..." | ||
| Vol 17, No 4 (2021) | Inflammation and Comorbidity. Are There any Chances to Improve the Prognosis in Patients with Extremely High Cardiovascular Risk? | Abstract similar documents |
| M. V. Zykov, O. L. Barbarash | ||
| "... atherosclerosis. The review provides numerous pathogenetic and clinical evidence for the effectiveness ..." | ||
| Vol 20, No 1 (2024) | Prevention of complications during implantation of devices in arrhythmology, past, present and future | Abstract similar documents |
| O. R. Eshmatov, R. E. Batalov, S. N. Krivolapov, M. S. Khynin, E. S. Sitkova, L. A. Pokrovskaya, E. M. Berezina, V. V. Botvin | ||
| "... presents risk factors, microbiology and pathogenesis, as well as the rationale and evidence for the use ..." | ||
| Vol 12, No 2 (2016) | SYSTEMATIC REVIEW AND META-ANALYSIS: PITFALLS OF METHODS | Abstract similar documents |
| Yu. V. Lukina, S. Yu. Martsevich, N. P. Kutishenko | ||
| "... meta-analysis is an analytical basis of evidence-based medicine, it is a very valuable tool ..." | ||
| Vol 7, No 3 (2011) | VALUE OF NICOTINIC ACID IN THE CURRENT CARDIOLOGY | Abstract similar documents |
| E. P. Trukhacheva, M. V. Ezhov | ||
| "... lipoprotein(a), and will be able to reduce residual cardiovascular risk. Evidence-based medicine data ..." | ||
| 1 - 100 of 274 Items | 1 2 3 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
